WASHINGTON, Dec 28 (Reuters) - German pharmaceutical company
Boehringer Ingelheim agreed to divest five types of animal
health products to settle charges that a proposed asset swap
with Sanofi would harm competition, the U.S. Federal Trade
Commission said on Wednesday.
Read more
No comments:
Post a Comment